The Effect of Interferon Regulatory Factor-1 on Apoptosis Regulation in Osteosarcomawith Different P53 Status

Xiong Jian,Chen Liaobin,Lu Hougeng,She Yuanju,Xu Yongtao
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2014.04.052
2014-01-01
Abstract:Objective Detect the effects of interferon regulatory factor-1 (IRF-1) gene on the apoptosisregulation in osteosarcoma with different p53 status and disclose the underlying mechnisms preliminarily.Methods To observe the effects of IRF-1 gene on the apoptosis effects induced by chemotherapeutic agent adriamycin in steosarcoma with different p53 status,p53 +/+ U2OS and p53-/-SaOS-2 were used.Western blotting analysis was firstly used to detect the expression of IRF-1 protein in adriamycin treated p53 +/+ U2OS and p53-/-SaOS-2 cells.And then IRF-1 gene was further overexpressed or knocked out for further detection the apoptosis effect induced by adriamycin respectively.Meanwhile,the target genes of p53,B cell lymphoma/leukemia-2 associated X protein (bax) and p21,were detected by real-time reverse transcriptase-polymerase chain reaction (RT-qPCR).Results Western blotting showed that the expression of IRF-1 has been improved significantly when p53 +/+ U2OS and p53-/-SaOS-2 were treated with adriamycin for 24 h.The significant increase in the death rate of cells has been detected by the release of lactate dehydrogenase (LDH) Activity (P < 0.05).When IRF-1 gene were overexpressed with transient transfection,adriamycin-induced apoptosis effect were increased significantly (P < 0.05),while the knockdown of IRF-1 gene by small interfering RNA (siRNA) transfection were decreased significantly (P < 0.05).RT-qPCR were used to further detected the expression of downstream target genes bax and p21,which do great favor to p53-dependent apoptosis.The results showed that bax and p21 were both upregulated significantly in p53-/-osteosarcoma cells (P < 0.05),but not observed in p53 +/+ osteosarcoma cells (P > 0.05).Conclusion IRF-1 plays a crucial role in adrymycin induced apoptosis by modulating p53 target genes,especially to the cancer cells with p53 gene deficient.
What problem does this paper attempt to address?